• 656 Citations
  • 9 h-Index
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Elaine Y. L. Chung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Lymphoma Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Adult T Cell Leukemia Lymphoma Medicine & Life Sciences
Interleukin-10 Medicine & Life Sciences
trabectedin Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Macrophages Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2004 2019

1 Citation (Scopus)

PAK kinase inhibition has therapeutic activity in novel preclinical models of adult T-Cell leukemia/lymphoma

Chung, E. Y. L., Mai, Y., Shah, U. A., Wei, Y., Ishida, E., Kataoka, K., Ren, X., Pradhan, K., Bartholdy, B. A., Wei, X., Zou, Y., Zhang, J., Ogawa, S., Steidl, U. G., Zang, X., Verma, A. K., Janakiram, M. & Ye, B. H., Jun 15 2019, In : Clinical Cancer Research. 25, 12, p. 3589-3601 13 p.

Research output: Contribution to journalArticle

p21-Activated Kinases
Adult T Cell Leukemia Lymphoma
Therapeutics
Cell Survival
Protein Isoforms

The ETS inhibitors YK-4-279 and TK-216 are novel antilymphoma agents

Spriano, F., Chung, E. Y. L., Gaudio, E., Tarantelli, C., Cascione, L., Napoli, S., Jessen, K., Carrassa, L., Priebe, V., Sartori, G., Graham, G., Selvanathan, S. P., Cavalli, A., Rinaldi, A., Kwee, I., Testoni, M., Genini, D., Ye, B. H., Zucca, E., Stathis, A. & 3 others, Lannutti, B., Toretsky, J. A. & Bertoni, F., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 5167-5176 10 p.

Research output: Contribution to journalArticle

Lymphoma
Transcription Factors
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
RNA Helicases
2 Citations (Scopus)

Trabectedin is a novel chemotherapy agent for diffuse large B cell lymphoma

Spriano, F., Chung, E. Y. L., Panini, N., Cascione, L., Rinaldi, A., Erba, E., Stathis, A., D'Incalci, M., Bertoni, F. & Gatta, R., Mar 1 2019, In : British Journal of Haematology. 184, 6, p. 1022-1025 4 p.

Research output: Contribution to journalLetter

Open Access
trabectedin
Lymphoma, Large B-Cell, Diffuse
Lymphoma
Drug Therapy
7 Citations (Scopus)

North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies

Shah, U. A., Chung, E. Y. L., Giricz, O., Pradhan, K., Kataoka, K., Gordon-Mitchel, S., Bhagat, T. D., Mai, Y., Wei, Y., Ishida, E., Choudhary, G. S., Joseph, A., Rice, R., Gitego, N., Parrish, C., Bartenstein, M., Goel, S., Mantzaris, I., Shastri, A., Derman, O. & 13 others, Binder, A., Gritsman, K., Kornblum, N., Braunschweig, I., Bhagat, C., Hall, J., Graber, A., Ratner, L., Wang, Y., Ogawa, S., Verma, A. K., Ye, B. H. & Janakiram, M., Oct 4 2018, In : Blood. 132, 14, p. 1507-1518 12 p.

Research output: Contribution to journalArticle

Adult T Cell Leukemia Lymphoma
T-cells
Epigenomics
decitabine
Mutation Rate
11 Citations (Scopus)

Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma

Bernasconi, E., Gaudio, E., Lejeune, P., Tarantelli, C., Cascione, L., Kwee, I., Spriano, F., Rinaldi, A., Mensah, A. A., Chung, E. Y. L., Stathis, A., Siegel, S., Schmees, N., Ocker, M., Zucca, E., Haendler, B. & Bertoni, F., Sep 1 2017, In : British Journal of Haematology. 178, 6, p. 936-948 13 p.

Research output: Contribution to journalArticle

Lymphoma
Gene Expression Profiling
Biological Phenomena
cdc Genes
Neoplasms